June 27, 2017 / 11:22 AM / 25 days ago

BRIEF-Ra Pharmaceuticals announces data from phase 2 clinical trial of RA101495

1 Min Read

June 27 (Reuters) - Ra Pharmaceuticals Inc:

* Ra Pharmaceuticals announces initial data from phase 2 clinical trial of RA101495 in Pnh

* Ra Pharmaceuticals Inc - rapid declines in LDH and near-complete inhibition of hemolytic activity

* Ra Pharmaceuticals Inc - review of initial safety and efficacy data enables opening of Eculizumab switch cohort

* Ra Pharmaceuticals Inc - no safety or tolerability concerns identified; no injection site reactions in study Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below